Introducing peanut foods to babies
Part of Immune system & allergy clinical trials.
This study helps parents introduce peanut-containing foods to their 4-8 month old babies safely, with support and guidance. It aims to reduce the risk of peanut allergies by teaching families how to feed peanuts regularly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and the parent or legal guardian of the baby.
- You can speak and read English.
- Your baby is 4 to 8 months old.
- Your baby has never eaten peanut before.
- You are willing to bring your baby to a supervised peanut feeding event and follow up with the study team.
- Your baby does not have a known peanut allergy or a feeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether introducing common allergenic foods early and continuing them for six months can help prevent food allergies in infants. It is for babies who have not yet started these foods.
This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.
This study is observing children with food allergies who are willing to do an oral food challenge (eating the allergen in a safe clinic setting). It helps doctors learn more about how allergies affect children.
This trial studies an oral immunotherapy approach, where children take tiny, controlled amounts of certain allergy-causing foods to build tolerance. It may help reduce allergic reactions, but only if kids meet safety and monitoring requirements.
This study aims to identify markers in the blood that could help predict how severe a peanut allergy reaction might be. If you qualify, your child will undergo a supervised peanut challenge to see how their body responds.
This early-phase study tests a new investigational medication (MY006) to see if it is safe and how the body processes it. It is given to both healthy volunteers and people with peanut allergy. The goal is to gather safety information before larger trials.
Hear when a new Food Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.